Submissions from 2024
Expanding treatment options for patients with HER2+ metastatic breast cancer with margetuximab plus chemotherapy: a case report series., Reshma Mahtani, Natasha Harpalani, Fengting Yan, Kristen Phiel, and Iuliia Kovalenko
Evaluation of potential biomarkers for lenvatinib plus pembrolizumab among patients with advanced endometrial cancer: results from Study 111/KEYNOTE-146., Vicky Makker, Matthew H Taylor, Carol Aghajanian, Allen L Cohn, Marcia S Brose, Christopher Di Simone, Zhu Alexander Cao, Leah Suttner, Andrey Loboda, Razvan Cristescu, Petar Jelinic, Robert Orlowski, Lea Dutta, Junji Matsui, Corina E Dutcus, Yukinori Minoshima, and Mark J Messing
Plasma arginine as a predictive biomarker for outcomes with immune checkpoint inhibition in metastatic colorectal cancer: a correlative analysis of the CCTG CO.26 trial., Lucy X Ma, Emma Titmuss, Jonathan M Loree, Derek J Jonker, Hagen F Kennecke, Scott Berry, Felix Couture, Chaudhary E Ahmad, John R Goffin, Petr Kavan, Mohammed Harb, Bruce Colwell, Setareh Samimi, Benoit Samson, Tahir Abbas, Nathalie Aucoin, Francine Aubin, Sheryl Koski, Dongsheng Tu, Christopher O'Callaghan, and Eric X Chen
Hypoxia drives shared and distinct transcriptomic changes in two invasive glioma stem cell lines., Valerie J Marallano, Mary E Ughetta, Rut Tejero, Sidhanta Nanda, Rohana Ramalingam, Lauren Stalbow, Anirudh Sattiraju, Yong Huang, Aarthi Ramakrishnan, Li Shen, Alexandre Wojcinski, Santosh Kesari, Hongyan Zou, Alexander M Tsankov, and Roland H Friedel
The Dance Between Tumor Molecular Biology and Antitumor Immune Response., K A Margolin
Walking dose required to achieve a clinically meaningful reduction in cancer-related fatigue among patients with breast cancer receiving chemotherapy: A URCC NCORP nationwide prospective cohort study, L Mattick, Alison Conlin, and See full list of authors in comments
Implementation of a lisocabtagene maraleucel chimeric antigen receptor T-cell therapy outpatient monitoring program: Multicenter nursing/advanced practice provider perspectives., Nicole McEntee, Jacqueline Manago, ChiaChun Lu, and Lucy Holmes
Effects of vitamin D supplementation on a deep learning-based mammographic evaluation in SWOG S0812., Julia E McGuinness, Garnet L Anderson, Simukayi Mutasa, Dawn L Hershman, Mary Beth Terry, Parisa Tehranifar, Danika L Lew, Monica Yee, Eric A Brown, Sebastien S Kairouz, Nafisa Kuwajerwala, Therese B Bevers, John E Doster, Corrine Zarwan, Laura Kruper, Lori M Minasian, Leslie Ford, Banu Arun, Marian L Neuhouser, Gary E Goodman, Powel H Brown, Richard Ha, and Katherine D Crew
Immunogenomics and spatial proteomic mapping highlight distinct neuro-immune architectures in melanoma vs. non-melanoma-derived brain metastasis, Alberto Mendoza-Valderrey, Ethan Dettmann, Douglas Hanes, Daria Kessler, Ludmila Danilova, Kai Rau, Yueqin Quan, Stacey Stern, Garni Barkhoudarian, Carlo Bifulco, K A Margolin, Steven E Kolker, and Maria Ascierto
Immunogenomics and spatial proteomic mapping highlight distinct neuro-immune architectures in melanoma vs. non-melanoma-derived brain metastasis., Alberto Mendoza-Valderrey, Ethan Dettmann, Douglas Hanes, Daria Kessler, Ludmila Danilova, Kai Rau, Yueqin Quan, Stacey Stern, Garni Barkhoudarian, Carlo Bifulco, K A Margolin, Steven E Kolker, and Maria L. Ascierto
Impact of Pathologist-Directed Comprehensive Genomic Profiling in Advanced Non-Small-Cell Lung Cancer in a Large Healthcare System, R Meng, Carlo Bifulco, Brian Piening, and See full list of authors in comments
Dark immunopeptidome of head and neck squamous cell carcinoma in serial cell lines from a single patient during multimodality treatment time-course, R Meng, Eric Tran, and See full list of authors in comments
ASO Author Reflections: Cost Comparison of Extreme Oncoplastic Breast-Conserving Surgery and Mastectomy with Reconstruction., Janelle-Cheri Millen and Janie G Grumley
Correction: Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?, Janelle-Cheri Millen, Udai Sibia, Katherine Jackson, Stacey L Stern, Javier I J Orozco, Crystal E Fancher, and Janie Grumley
Comparing Costs: Does Extreme Oncoplastic Breast-Conserving Surgery Confer a Cost Benefit When Compared with Mastectomy and Reconstruction?, Janelle-Cheri Millen, Udai S Sibia, Katherine M Jackson, Stacey Stern, Javier I Orozco, Crystal E Fancher, and Janie Grumley
Mesenchymal stem cells - the secret agents of cancer immunotherapy: Promises, challenges, and surprising twists., Theia Minev, Shani Balbuena, Jaya Mini Gill, Francesco M Marincola, Santosh Kesari, and Feng Lin
A phase1 study of autologous engineered CD4+ and CD8+ T cells, HLA-A*11:01-restricted, KRAS G12V-specific, transgenic TCR; CD8α/β coreceptor and a FAS41BB switch receptor in patients with solid tumors, S Mitchell, Rom Leidner, and See full list of authors in comments
Induced collagen type-I secretion by hepatocytes of the melanoma liver metastasis is associated with a reduction in tumour-infiltrating lymphocytes., Shodai Mizuno, Matias A Bustos, Yoshinori Hayashi, Kodai Abe, Satoru Furuhashi, Yalda Naeini, Xiaowei Xu, Anton J Bilchik, and Dave SB Hoon
Tumour evolution and microenvironment interactions in 2D and 3D space., Chia-Kuei Mo, Jingxian Liu, Siqi Chen, Erik Storrs, Andre Luiz N Targino da Costa, Andrew Houston, Michael C Wendl, Reyka G Jayasinghe, Michael D Iglesia, Cong Ma, John M Herndon, Austin N Southard-Smith, Xinhao Liu, Jacqueline Mudd, Alla Karpova, Andrew Shinkle, S Peter Goedegebuure, Abdurrahman Taha Mousa Ali Abdelzaher, Peng Bo, Lauren Fulghum, Samantha Livingston, Metin Balaban, Angela Hill, Joseph E Ippolito, Vésteinn Thorsson, Jason M Held, Ian S Hagemann, Eric H Kim, Peter O Bayguinov, Albert H Kim, Mary M Mullen, Kooresh I Shoghi, Tao Ju, Melissa A Reimers, Cody Weimholt, Liang-I Kang, Sidharth V Puram, Deborah J Veis, Russell Pachynski, Katherine C Fuh, Milan G Chheda, William E Gillanders, Ryan C Fields, Benjamin J Raphael, Feng Chen, and Li Ding
An open-label, phase 1, multicenter study to evaluate the safety and preliminary anti-tumor activity of NT-112 in human leukocyte antigen-C*08:02–positive adult patients with unresectable, advanced, and/or metastatic solid tumors that are positive for the KRAS G12D mutation, MP Morelli, Rom Leidner, and See full list of authors in comments
Genomic, immunologic, and prognostic associations of TROP2 (TACSTD2) expression in solid tumors., Dan Morgenstern-Kaplan, Samuel A Kareff, Asaad Trabolsi, Estelamari Rodriguez, Harris Krause, Jennifer R Ribeiro, Heng Tan, Emmanuel S Antonarakis, Emil Lou, Misako Nagasaka, Sandra Algaze, Heinz-Josef Lenz, Stephen V Liu, Balazs Halmos, Dave S B Hoon, Andreas Seeber, Patrick C Ma, Wafik S El-Deiry, Ari M Vanderwalde, and Gilberto Lopes
A phase 1/1b study of the IL-2 prodrug WTX-124 in patients with locally advanced or metastatic solid tumors after checkpoint inhibitor therapy: Initial results of the combination dose escalation with pembrolizumab, J Moser, Brendan Curti, and See full list of authors in comments
Comparative analysis of immune infiltrates in head and neck cancers across anatomical sites., Tara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, Arjen Brink, Changlin Ke, Joseph Fass, Venkatesh Rajamanickam, C René Leemans, Yoshinobu Koguchi, Bernard A Fox, Jos B Poell, Ruud H Brakenhoff, and Rieneke van de Ven
Immune cell topography of head and neck cancer., Tara Muijlwijk, Dennis N L M Nijenhuis, Sonja H Ganzevles, Fatima Ekhlas, Carmen Ballesteros-Merino, Laura A N Peferoen, Elisabeth Bloemena, Bernard A Fox, Jos B Poell, C René Leemans, Ruud H Brakenhoff, and Rieneke van de Ven
Inhibition of lysine acetyltransferase KAT6 in ER+HER2- metastatic breast cancer: a phase 1 trial, Toru Mukohara, Yeon Hee Park, David Sommerhalder, Kan Yonemori, Erika Hamilton, Sung-Bae Kim, Jee Hyun Kim, Hiroji Iwata, Toshinari Yamashita, Rachel M Layman, Monica Mita, Timothy Clay, Yee Soo Chae, Catherine Oakman, Fengting Yan, Gun Min Kim, Seock-Ah Im, Geoffrey J Lindeman, Hope S Rugo, Marlon Liyanage, Michelle Saul, Christophe Le Corre, Athanasia Skoura, Li Liu, Meng Li, and Patricia M LoRusso
Evaluation of the EMulate Therapeutics Voyager's ultra-low radiofrequency energy in murine model of glioblastoma., Rajesh Mukthavaram, Pengfei Jiang, Sandra Pastorino, Natsuko Nomura, Feng Lin, and Santosh Kesari
Tissue-specific thresholds of mutation burden associated with anti-PD-1/L1 therapy benefit and prognosis in microsatellite-stable cancers., Maishara Muquith, Magdalena Espinoza, Andrew Elliott, Joanne Xiu, Andreas Seeber, Wafik El-Deiry, Emmanuel S Antonarakis, Stephanie L Graff, Michael J Hall, Hossein Borghaei, Dave S B Hoon, Stephen V Liu, Patrick C Ma, Rana R McKay, Trisha Wise-Draper, John Marshall, George W Sledge, David Spetzler, Hao Zhu, and David Hsiehchen
Imaging as an early biomarker to predict sensitivity to everolimus for progressive NF2-related vestibular schwannoma., Phioanh Leia Nghiemphu, Jeremie Vitte, Eva Dombi, Thien Nguyen, Naveed Wagle, Akira Ishiyama, Ali R Sepahdari, David Cachia, Brigitte C Widemann, Derald E Brackmann, Joni K Doherty, Michel Kalamarides, and Marco Giovannini
Integrated Antigenic and Nucleic Acid Detection in Single Virions and Extracellular Vesicles with Viral Content., Kim Truc Nguyen, Xilal Y Rima, Luong T H Nguyen, Xinyu Wang, Kwang Joo Kwak, Min Jin Yoon, Hong Li, Chi-Ling Chiang, Jacob Doon-Ralls, Kelsey Scherler, Shannon Fallen, Stephanie L Godfrey, Julie A Wallick, Setty M Magaña, Andre F Palmer, Inyoul Lee, Christopher C Nunn, Kimberly M Reeves, Henry G Kaplan, Jason D Goldman, James R Heath, Kai Wang, Preeti Pancholi, L James Lee, and Eduardo Reátegui
Phase 1/2 Trial of ASP1570, a Novel Diacylglycerol Kinase ζ Inhibitor, in Patients With Advanced Solid Tumors, D Olson, David J. Park, and See full list of authors in comments
Biological effects of intraoperative radiation therapy: histopathological changes and immunomodulation in breast cancer patients., Javier I Orozco, Betsy Valdez, Chikako Matsuba, Michael P Simanonok, Miquel Ensenyat-Mendez, Judi Anne B Ramiscal, Matthew P Salomon, Yuki Takasumi, and Janie Grumley
A phase II study of nivolumab, ipilimumab plus bicalutamide in metastatic breast cancer, David Page and See all authors in comments
Pilot evaluation of portable scalp cooling for chemotherapy-associated alopecia in early-stage breast cancer, David Page and See full list of authors in comments
Adjuvant Radiotherapy for Surgically Resected Stage III Merkel Cell Carcinoma., Seyed Saeed Pairawan, Chloe E Dominguez, Naveenraj Solomon, David Caba-Molina, Michael O'Leary, Mark E Reeves, and Jukes P Namm
A genome scale transcriptional regulatory model of the human placenta., Alison Paquette, Kylia Ahuna, Yeon Mi Hwang, Jocelynn Pearl, Hanna Liao, Paul Shannon, Leena Kadam, Samantha Lapehn, Matthew Bucher, Ryan Roper, Cory C Funk, James MacDonald, Theo Bammler, Priyanka Baloni, Heather Brockway, W Alex Mason, Nicole Bush, Kaja Z Lewinn, Catherine J Karr, John Stamatoyannopoulos, Louis J Muglia, Helen Jones, Yoel Sadovsky, Leslie Myatt, Sheela Sathyanarayana, and Nathan D Price
Augmenting colonoscopy with AI: insights and future directions., Sravanthi Parasa
Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells., James H Park, Parvinder Hothi, Adrian Lopez Garcia de Lomana, Min Pan, Rachel Calder, Serdar Turkarslan, Wei-Ju Wu, Hwahyung Lee, Anoop P Patel, Charles Cobbs, Sui Huang, and Nitin Baliga
Gene regulatory network topology governs resistance and treatment escape in glioma stem-like cells., James H Park, Parvinder Hothi, Adrian Lopez Garcia de Lomana, Min Pan, Rachel Calder, Serdar Turkarslan, Wei-Ju Wu, Hwahyung Lee, Anoop P Patel, Charles Cobbs, Sui Huang, and Nitin S Baliga
A phase 1, open-label, dose escalation study of the safety and tolerability of ANK-101 in advanced solid tumors, JC Park, Brendan Curti, and See full list of authors in comments
A phase 1, open-label, dose escalation study on the safety and tolerability of ANK-101 in advanced solid tumors, Jong Chul Park, Brendan Curti, and See full list of authors in comments
Posterior Ischemic Optic Neuropathy Because of Hematologic Malignancy., Ankush U Patel, Uresh S Patel, and Eugene May
7P Patient-relevant endpoints from PAPILLON: Amivantamab plus chemotherapy vs chemotherapy as first-line treatment of EGFR exon 20 insertion-mutated (Ex20ins) advanced NSCLC, L Paz-Ares, Rachel E Sanborn, and See full list of authors in comments
Genetic Links between Endometriosis and Endometriosis-Associated Ovarian Cancer-A Narrative Review (Endometriosis-Associated Cancer)., Tanja Pejovic, Ann M Cathcart, Rofieda Alwaqfi, Marjorie N Brooks, Rachel Kelsall, and Farr R Nezhat
Association between class III obesity and overall survival in previously untreated younger patients with acute myeloid leukemia enrolled on SWOG S1203, Mary-Elizabeth Percival, Michelle Zhang, Megan Othus, Kerry McMillen, Harry Erba, Guillermo Garcia-Manero, John Pagel, and Mohamed Sorror
Standardizing Chemotherapy Education Patient Practices to Increase Nurses’ Self-Efficacy, Julia Persons
Safety and efficacy of acalabrutinib plus bendamustine and rituximab in patients with treatment-naive or relapsed / refractory mantle cell lymphoma: phase Ib trial., Tycel Phillips, Michael Wang, Tadeusz Robak, David Gallinson, Don Stevens, Krish Patel, Safaa Ramadan, Chuan-Chuan Wun, Wojciech Jurczak, and Stephen D Smith
Interrogating Tumor Structural Variation and Nongenic Dark Matter with Whole-Transcriptome Profiling, Brian Piening
Strategies for Spatial and Multi-omic Profiling of Histopathology Tissue Specimens, Brian Piening
Strategies for spatial multi-omic profiling of histopathology tissues, Brian Piening
Author Correction: BRAF, David Planchard, Rachel E Sanborn, Marcelo V Negrao, Aria Vaishnavi, and Egbert F Smit
BRAF(V600E)-mutant metastatic NSCLC: disease overview and treatment landscape, David Planchard, Rachel E Sanborn, Marcelo V Negrao, Aria Vaishnavi, and Egbert F Smit
Phase I/II study of Safety and Efficacy of Intraperitoneal IMNN-001 with Neoadjuvant Chemotherapy of Paclitaxel and Carboplatin in Patients Newly Diagnosed with Advanced Epithelial Ovarian Cancer, TH Premal, C Darus, and See full list of authors in comments
Circulating cancer-specific CD8 T cell frequency is associated with response to PD-1 blockade in Merkel cell carcinoma., Thomas Pulliam, Saumya Jani, Lichen Jing, Heeju Ryu, Ana Jojic, Carolyn Shasha, Jiajia Zhang, Rima Kulikauskas, Candice Church, Charlie Garnett-Benson, Ted Gooley, Aude Chapuis, Kelly G Paulson, Kellie N Smith, Drew M Pardoll, Evan W Newell, David M Koelle, Suzanne L Topalian, and Paul Nghiem
Mutation Patterns Predict Drug Sensitivity in Acute Myeloid Leukemia., Guangrong Qin, Jin Dai, Sylvia Chien, Timothy J Martins, Brenda Loera, Quy H Nguyen, Melanie L Oakes, Bahar Tercan, Boris Aguilar, Lauren Hagen, Jeannine McCune, Richard Gelinas, Raymond J Monnat, Ilya Shmulevich, and Pamela S Becker
Knowledge graphs facilitate prediction of drug response for acute myeloid leukemia., Guangrong Qin, Yue Zhang, Jeffrey W Tyner, Christopher J Kemp, and Ilya Shmulevich
Genome-wide association analyses of ovarian cancer patients undergoing primary debulking surgery identify candidate genes for residual disease., Dhanya Ramachandran, Jonathan P Tyrer, Stefan Kommoss, Anna DeFazio, Marjorie J Riggan, AOCS Group, Penelope M Webb, Peter A Fasching, Diether Lambrechts, María J García, Cristina Rodríguez-Antona, Marc T Goodman, Francesmary Modugno, Kirsten B Moysich, Beth Y Karlan, Jenny Lester, Susanne K Kjaer, Allan Jensen, Estrid Høgdall, Ellen L Goode, William A Cliby, Amanika Kumar, Chen Wang, Julie M Cunningham, Stacey J Winham, Alvaro N Monteiro, Joellen M Schildkraut, Daniel W Cramer, Kathryn L Terry, Linda Titus, Line Bjorge, Liv Cecilie Vestrheim Thomsen, OPAL Study Group, Tanja Pejovic, Claus K Høgdall, Iain A McNeish, Taymaa May, David G Huntsman, Jacobus Pfisterer, Ulrich Canzler, Tjoung-Won Park-Simon, Willibald Schröder, Antje Belau, Lars Hanker, Philipp Harter, Jalid Sehouli, Rainer Kimmig, Nikolaus de Gregorio, Barbara Schmalfeldt, Klaus Baumann, Felix Hilpert, Alexander Burges, Boris Winterhoff, Peter Schürmann, Lisa-Marie Speith, Peter Hillemanns, Andrew Berchuck, Sharon E Johnatty, Susan J Ramus, Georgia Chenevix-Trench, Paul D P Pharoah, Thilo Dörk, and Florian Heitz
Norepinephrine induces anoikis resistance in high-grade serous ovarian cancer precursor cells., Hunter D Reavis, Stefan M Gysler, Grace B McKenney, Matthew Knarr, Hannah J Lusk, Priyanka Rawat, Hannah S Rendulich, Marilyn A Mitchell, Dara S Berger, Jamie Moon, Suyeon Ryu, Monica Mainigi, Marcin P Iwanicki, Dave Hoon, Laura M Sanchez, and Ronny Drapkin
Intraoperative Molecular Imaging With Pafolacianine in Resection of Occult Pulmonary Malignancy in the ELUCIDATE Trial., David Rice, Sunil Singhal, Emma Niemeyer, Inderpal Sarkaria, Linda W Martin, Michael I Ebright, Brian Louie, Tommy Lee, and Jarrod D Predina
[Not Available]., Susan L Richardson
My achy brachy heart: Resuscitating medical physics brachytherapy resident training., Susan L Richardson, Manik Aima, Samantha J Simiele, and Christopher S Melhus
Order From Chaos: The Benefits of Standardized Nomenclature in Radiation Oncology., Susan L Richardson, Walter R Bosch, Charles S Mayo, Todd R McNutt, Jean M Moran, Richard A Popple, Ying Xiao, and Elizabeth L Covington
Going to MARS may shorten our patient's survival, R Taylor Ripley, Prasad S Adusumilli, Adam J Bograd, Servet Bölükbas, Raphael Bueno, Robert B Cameron, Marc de Perrot, Raja M Flores, Shawn G Groth, Loïc Lang-Lazdunski, David H Harpole, Harvey I Pass, Meera Patel, Isabelle Schmitt-Opitz, Paula Antonia Ugalde Figueroa, and Andrea S Wolf
American Association of Neurological Surgeons/Congress of the Neurological Surgeons Section on Tumors Guidelines: Assessing Their Impact on Brain Tumor Clinical Practice., Faith C Robertson, Brian V Nahed, Garni Barkhoudarian, Anand Veeravagu, David Berg, Steven Kalkanis, Jeffrey J Olson, and Isabelle M Germano
Safety of Extended Pirtobrutinib Exposure in Relapsed and/or Refractory B-Cell Malignancies., Lindsey E Roeker, Catherine C Coombs, Nirav N Shah, Wojciech Jurczak, Jennifer A Woyach, Chan Y Cheah, Krish Patel, Kami Maddocks, Yucai Wang, Pier Luigi Zinzani, Talha Munir, Youngil Koh, Meghan C Thompson, Catherine E Muehlenbein, Chunxiao Wang, Richard Sizelove, Sarang Abhyankar, Safarulla Hasanabba, Donald E Tsai, Toby A Eyre, and Michael Wang
Histotripsy-A Novel and Intriguing Technique of Liver Ablation., Colin J Rog, Mohamed Alassas, and Evan Ong
Fatal borealpox in an immunosuppressed patient treated with antivirals and vaccinia immunoglobulin - Alaska, 2023., Julia H Rogers, Benjamin Westley, Thomas Mego, Katherine G Newell, John Laurance, Lisa Smith, Jayme Parker, Sarah Y Park, Shivkumar Venkatasubrahmanyam, Nicholas Noll, Sivan Bercovici, Agam K Rao, Andrea M McCollum, Whitni Davidson, William C Carson, Michael B Townsend, Jeffrey B Doty, Christina Hutson, Yu Li, Kimberly Wilkins, Jiusheng Deng, Crystal M Gigante, Panayampalli S Satheshkumar, Alexandra Tuttle, Julian A Villalba, Julu Bhatnagar, Sarah Reagan-Steiner, Louisa J Castrodale, and Joseph B McLaughlin
Developmental and functional differences between CD39+CD103+ DP CD8 T cells from normal colon and tumor in CRC patients, W Rosales, Thomas Duhen, and See full list of authors in comments
Perceptions of multi-cancer early detection tests among communities facing barriers to health care., Kristi L Roybal, Robyn A Husa, Maria Connolly, Catherine T Dinh, Kara M. Bensley, and Staci J. Wendt
Plain language summary of PAPILLON: amivantamab plus chemotherapy in untreated, Joshua K Sabari, Nicolas Girard, Aaron S Mansfield, Rachel E Sanborn, Trishala Agrawal, Caicun Zhou, and Keunchil Park
Regorafenib in Patients With Solid Tumors With, Vaibhav Sahai, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Vijay Suhag, Elie G Dib, Inderjit Mehmi, Kunal C Kadakia, Evan Pisick, Herbert L Duvivier, Phat Le, Rui Li, David P Michelin, Ryan E Wilcox, Gina N Grantham, Dominique C Hinshaw, Abigail Gregory, Susan Halabi, and Richard L Schilsky
Deep learning serial CT response score predicts overall survival in advanced NSCLC treated with PD-(L)1 immune checkpoint inhibitors, C Sako, Brendan Curti, and See full list of authors in comments
First-in-human (FIH) phase I data of HST-1011, an oral CBL-B inhibitor, in patients with advanced solid tumors, Rachel Sanborn
Is Perioperative Immunotherapy the New Standard of Care, Rachel Sanborn
Small cell lung cancer takes the stage, Rachel E Sanborn
Social determinants of health and variability in treatment for patients with early-stage Non-Small Cell Lung Cancer., Molly Scannell Bryan, Xiaohan Hu, Monika A Izano, Hina Mohammed, Marianna Wicks, Thomas Brown, George Simon, Henry Kaplan, and Anna Berry
Development and Implementation of the Zone Tool for Oncology: A Simple Patient Teaching Tool, Deanna Schlifke, Lin Michelle Tabar, Mary Baker, and Sarah Sumner
VGLL-fusions define a new class of intraparenchymal CNS schwannoma., Simone Schmid, Kanish Mirchia, Anna Tietze, Ilon Liu, Christin Siewert, Jakob Nückles, Jens Schittenhelm, Felix Behling, Matija Snuderl, Christian Hartmann, Sebastian Brandner, Simon M L Paine, Andrey Korshunov, Martin Hasselblatt, Roland Coras, Sridhar Epari, Christine Stadelmann, Sabrina Zechel, Michèle Simon, Yelena Wilson, Francesca Gianno, G Lucas Calixto-Hope, Viktor Zherebitskiy, Vassil B Kaimaktchiev, Lorraina Robinson, Kenneth Aldape, Eelco W Hoving, Bastiaan B J Tops, Ashwyn Augustine Perera, Pauline Göller, Pablo Hernáiz Driever, Pieter Wesseling, Arend Koch, Arie Perry, Felix Sahm, David T W Jones, and David Capper
Exploring the Genomic Landscape of Hepatobiliary Cancers to Establish a Novel Molecular Classification System., Anthony J Scholer, Rebecca Marcus, Mary Garland-Kledzik, Debopriya Ghosh, Miquel Ensenyat-Mendez, Joshua Germany, Juan A Santamaria-Barria, Adam Khader, Javier I Orozco, and Melanie Goldfarb
Palbociclib in Patients With Soft Tissue Sarcoma With, Scott Schuetze, Michael Rothe, Pam K Mangat, Elizabeth Garrett-Mayer, Funda Meric-Bernstam, Carmen J Calfa, Laura Catherine Farrington, Michael B Livingston, Kristopher Wentzel, Deepti Behl, Yelena Kier, Alissa S Marr, Margaret von Mehren, Joshua Press, Ramya Thota, Gina N Grantham, Abigail Gregory, Dominique C Hinshaw, Susan Halabi, and Richard L Schilsky
Pirtobrutinib monotherapy in Bruton tyrosine kinase inhibitor-intolerant patients with B-cell malignancies: results of the phase I/II BRUIN trial., Nirav H Shah, Michael Wang, Lindsey E Roeker, Krish Patel, Jennifer A Woyach, William G Wierda, Chaitra S Ujjani, Toby A Eyre, Pier Luigi Zinzani, Alvaro J Alencar, Paolo Ghia, Nicole Lamanna, Marc S Hoffmann, Manish R Patel, Ian Flinn, James N Gerson, Shuo Ma, Catherine C Coombs, Chan Y Cheah, Ewa Lech-Maranda, Bita Fakhri, Won Seog Kim, Minal A Barve, Jonathon B Cohen, Wojciech Jurczak, Talha Munir, Meghan C Thompson, Donald E Tsai, Katherine Bao, Nicholas A Cangemi, Jennifer F Kherani, Richard A Walgren, Hongmei Han, Amy S Ruppert, and Jennifer R Brown
Pathologic Features of Miscellaneous Foregut Malignancies., Mark Sharobim, Eduard Matkovic, Michael Schwalbe, and Kristina A Matkowskyj
Trifecta Outcomes After Use of 3-Dimensional Digital Models for Planning of Robotic Prostatectomy: A Secondary Analysis of a Randomized Clinical Trial., Joseph D Shirk, Robert E Reiter, Eric M Wallen, Raymond W Pak, Thomas Ahlering, Ketan K Badani, and James R Porter
Socially vulnerable patients are more likely to fail outpatient management of symptomatic cholelithiasis., Udai S Sibia, John R Klune, Cristina B Feather, Deanna Rider, Douglas Hanes, and Richard Essner
Analysis of 10-year trends in Medicare Physician Fee Schedule payments in surgery., Udai S Sibia, Janelle-Cheri Millen, John R Klune, Anton Bilchik, and Leland J Foshag
Impact of Fall Education to Oncology Staff on Oncology Patient Fall Rates, Danni Sloane
Impact of oral melatonin supplementation on urine and serum melatonin concentrations and quality-of-life measures in persons with relapsing multiple sclerosis., Kyle E Smoot, Tiffany Gervasi-Follmar, Horia Marginean, Chiayi Chen, and Stanley Cohan
Complications and adverse events in lymphadenectomy of the inguinal area: worldwide expert consensus., René Sotelo, Aref S Sayegh, Luis G Medina, Laura C Perez, Anibal La Riva, Michael B Eppler, José Gaona, Marcos Tobias-Machado, Philippe E Spiess, Curtis A Pettaway, Antonio Carlos Lima Pompeo, Pablo Aloisio Lima Mattos, Timothy G Wilson, Gustavo M Villoldo, Eric Chung, Aldo Samaniego, Antonio Augusto Ornellas, Vladimir Pinheiro, Eder S Brazão, David Subira-Rios, Leandro Koifman, Stênio de Cassio Zequi, Humberto M Pontillo Z, José de Ribamar Rodrigues Calixto, Rafael Campos Silva, B Mark Smithers, Simone Garzon, Oliver Haase, Antonio Sommariva, Robert Fruscio, Francisco Martins, Pedro S de Oliveira, Giovanni Battista Levi Sandri, Marco Clementi, Juan Astigueta, Islam H Metwally, Rasiah Bharathan, Tarun Jindal, Yasuhiro Nakamura, Hisham Abdel Mageed, Sakthiushadevi Jeevarajan, Ramón Rodriguez Lay, Herney Andrés García-Perdomo, Omaira Rodríguez González, Saum Ghodoussipour, Inderbir Gill, and Giovanni E Cacciamani
Consensus Recommendations from the 2024 Lymphoma Research Foundation Workshop on Treatment Selection and Sequencing in CLL or SLL., Jacob D Soumerai, Jacqueline Claudia Barrientos, Inhye E Ahn, Catherine C Coombs, Douglas E Gladstone, Marc S Hoffmann, Adam S Kittai, Ryan W Jacobs, Andrew Lipsky, Krish Patel, Joanna M Rhodes, Alan P Skarbnik, Meghan C Thompson, Daniel A Ermann, Patrick K Reville, Harsh R Shah, Jennifer R Brown, and Deborah M Stephens
Safety and efficacy of zandelisib plus zanubrutinib in previously treated follicular and mantle cell lymphomas., Jacob D Soumerai, Catherine S Diefenbach, Deepa Jagadeesh, Adam Asch, Abhijeet Kumar, Michaela L Tsai, Thomas A Jandl, Izidore S Lossos, Vaishalee P Kenkre, Farrukh Awan, William Novotny, Jane Huang, Lu Miao, Prabhu Rajagopalan, Richard G Ghalie, and Andrew D Zelenetz
First-in-human study of CDR404, a novel bivalent and bispecific, antibody-derived, T cell engager in MAGE-A4-positive advanced solid cancers, I Spanggaard, Rom Leidner, and See full list of authors in comments
ALLO-316 in patients with advanced or metastatic clear cell renal cell carcinoma (ccRCC): updated safety and efficacy from the phase 1 TRAVERSE multicenter study, SA Srour, Brendan Curti, and See full list of authors in comments
Breast Cancer Immunology, Sasha Stanton
Developing immune therapies for prevention in breast cancer, Sasha Stanton
From Receptor Buckets to Receptor Spectrum Guiding Breast Cancer Therapy, Sasha Stanton
HER2 Positive Breast Cancer, Sasha Stanton
Hormone Receptor Positive Breast Cancer, Sasha Stanton
Immunology 101, Sasha Stanton
